Modeling Propofol Doses for Dogs with Liver Issues
Author Information
Author(s): Gonzaga Lucas Wamser Fonseca, Egito Beatriz Monte, Coelho João Bosco Costa, Souza Gabriela Pereira, Martins Frederico Severino, Ferrante Marcos
Primary Institution: Universidade Federal de Lavras
Hypothesis
Can a physiologically based pharmacokinetic (PBPK) model accurately predict propofol doses for canines with hepatic impairment?
Conclusion
The study demonstrates that a PBPK model can effectively predict propofol dosing in canines, particularly those with liver impairment, enhancing safety and efficacy in anesthesia.
Supporting Evidence
- The PBPK model showed good predictive performance with a geometric mean fold error ranging from 0.8 to 1.25.
- More than 95% of 1000 simulated canines maintained propofol concentrations within the target range.
- Recovery time increased significantly with the level of hepatic impairment, indicating a strong relationship between liver function and anesthesia recovery.
Takeaway
This study created a computer model to help veterinarians give the right amount of anesthesia to dogs with liver problems, making it safer for them.
Methodology
The study involved creating a PBPK model for healthy canines and adjusting it for those with varying degrees of hepatic impairment, validated against data from multiple studies.
Limitations
The model's predictions may need further refinement and validation in real clinical settings.
Participant Demographics
Simulated population of canines with varying degrees of hepatic impairment (20%, 40%, 60%, and 80%) and healthy canines.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website